Active Biotech AB (publ) (FRA:BTPC)

Germany flag Germany · Delayed Price · Currency is EUR
0.0031
+0.0005 (19.23%)
At close: Dec 4, 2025
19.23%
Market Cap 7.19M
Revenue (ttm) n/a
Net Income (ttm) -3.48M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 9,297
Open 0.0031
Previous Close 0.0026
Day's Range 0.0031 - 0.0031
52-Week Range 0.0001 - 0.0307
Beta n/a
RSI 42.07
Earnings Date Feb 12, 2026

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as non-infectious uveitis; Tasquinimod, an orally active small molecule immunomodulator that blocks tumor-promoting signals in the bone marrow microenvir... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 6
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BTPC
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.